High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study-Reference-Cited by-同舟云学术

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

Published:2007-01-26 Issue:6 Volume:59 Page:771-779
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Tedeschi Alessandra,Montillo Marco,Strocchi Elena,Cafro Anna Maria,Tresoldi Elisabetta,Intropido Liliana,Nichelatti Michele,Marbello Laura,Baratè Claudia,Camaggi Carlo Maurizio,Morra Enrica

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-006-0332-4.pdf

Reference33 articles.

1. Hoelzer D (1993) Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin North Am 7:139–160

2. Garcia-Manero G, Thomas DA (2001) Salvage therapy for refractory or relapsed adult acute lymphoblastic leukemia. Hematol Oncol Clin North Am 15:163–205

3. Weiss MA (1997) Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). Leukemia 11:S28–S30

4. Feldaman EJ (2000) High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia. Leuk Res 24:189–191

5. Welborn JL (1994) Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am J Hematol 45:341–344

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia;Nature Communications;2021-11-26

2. Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring;Molecules;2020-12-09

3. Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1;Leukemia;2017-07-28

4. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption;Oncotarget;2016-11-19

5. Phase I study of idarubicin dose escalation for remission induction therapy in acute myeloid leukemia;Leukemia & Lymphoma;2016-02-15